资讯

TipRanks on MSN5 天

AbbVie’s New Study on Ulcerative Colitis: A Potential Game Changer?

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is conducting a Phase 3b clinical study ...